| Bioactivity | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine |
| CAS | 16321-99-6 |
| Formula | C16H18ClN5O7 |
| Molar Mass | 427.80 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2′,3′,5′-Tri-O-acetyl-6-chloroguanosine
CAS: 16321-99-6 F: C16H18ClN5O7 W: 427.80
2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.